Quarterly report · Q3
2413.TEDINET S100SS2U
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥179.2bn | 2023-04-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥63.4bn | 2023-10-01 → 2023-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥230.8bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥175.2bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥62.5bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥55.0bn | 2023-04-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥20.4bn | 2023-10-01 → 2023-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥58.7bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥22.4bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥57.3bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥20.0bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥74.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥60.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥22.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥36.6bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥13.2bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥49.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥39.3bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥15.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥38.9bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥13.8bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥41.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥15.9bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥463.8bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥400.6bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥380.7bn | at 2022-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥112.7bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥91.1bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥351.1bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥309.5bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥297.4bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥264.0bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥337.1bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥302.6bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥290.7bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥143.1bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥109.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥104.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥35.6bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥57.1bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥33.4bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥26.3bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥21.9bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥8.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥13.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥22.8bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥20.7bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥53.93 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥19.45 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥72.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥57.86 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥22.42 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥53.89 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.44 | 2023-10-01 → 2023-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥72.17 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥57.82 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.4 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.7% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 75.5% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 76.4% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 107
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥2.6bn |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2023-12-31 | −¥779m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥2.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2023-12-31 | −¥779m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥459m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2023-12-31 | −¥584m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥12.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥3.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥12.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥3.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥31m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥10m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥3.9bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥549m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥20.3bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥6.5bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥20.1bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥248m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥32m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥5.1bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥71.5bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥26.0bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥69.3bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥25.3bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥710m |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥30.4bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥11.9bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥52.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥19.5bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥52.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥19.5bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥15m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥4m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥12.9bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥5.6bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥23.4bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥23.4bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥10m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥3m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.6bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥842m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥179.8bn |
| —segment total | revenue | 2023-10-01 → 2023-12-31 | ¥63.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥177.3bn |
| —segment total | revenue external | 2023-10-01 → 2023-12-31 | ¥62.7bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.5bn |
| —segment total | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥759m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥54.9bn |
| —segment total | segment profit | 2023-10-01 → 2023-12-31 | ¥20.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥3.9bn |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥3.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥418m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥11.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.8bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥623m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥178m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥4.2bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥734m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥20.6bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥6.6bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.1bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥521m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥174m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.0bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥69.8bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥27.2bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥67.4bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥26.5bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.4bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥739m |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥32.1bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥13.3bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥47.3bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥17.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥47.2bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥17.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥21m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥17m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥13.9bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥27.5bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥27.2bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥304m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥917m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥176.6bn |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥62.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥172.8bn |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥61.6bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| —segment total | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥1.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥59.5bn |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | ¥22.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 773
| Item | Context | Value | Unit |
|---|---|---|---|
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000CareerSolutionReportableSegmentMember | 31000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000SiteSolutionReportableSegmentMember | 10000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000OverseasReportableSegmentMember | 15000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReportableSegmentsMember | 2504000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000OtherEmergingBusinessMember | 62000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -2567000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration | － | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000MedicalPlatformReportableSegmentMember | 71480000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000EvidenceSolutionReportableSegmentMember | 20321000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000CareerSolutionReportableSegmentMember | 12530000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000SiteSolutionReportableSegmentMember | 23368000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000OverseasReportableSegmentMember | 52123000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReportableSegmentsMember | 179822000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000OtherEmergingBusinessMember | 1934000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -2567000000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 179189000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000MedicalPlatformReportableSegmentMember | 30369000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000EvidenceSolutionReportableSegmentMember | 5121000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000CareerSolutionReportableSegmentMember | 3887000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000SiteSolutionReportableSegmentMember | 2618000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000OverseasReportableSegmentMember | 12894000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReportableSegmentsMember | 54889000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000OtherEmergingBusinessMember | 533000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | -459000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 54963000000 | JPY |
| Finance income and expenses net IFRS | CurrentYTDDuration | 2361000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 57325000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000MedicalPlatformReportableSegmentMember | 2115000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000EvidenceSolutionReportableSegmentMember | 416000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000CareerSolutionReportableSegmentMember | 97000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000SiteSolutionReportableSegmentMember | 1230000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000OverseasReportableSegmentMember | 2473000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_ReportableSegmentsMember | 6332000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_jpcrp040300-q3r_E05425-000OtherEmergingBusinessMember | 123000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYTDDuration | 6454000000 | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000MedicalPlatformReportableSegmentMember | 26487000000 | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000EvidenceSolutionReportableSegmentMember | 6424000000 | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000CareerSolutionReportableSegmentMember | 2915000000 | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000SiteSolutionReportableSegmentMember | 8751000000 | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000OverseasReportableSegmentMember | 17056000000 | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration_ReportableSegmentsMember | 61633000000 | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000OtherEmergingBusinessMember | 905000000 | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | Prior1QuarterDuration | 62538000000 | JPY |
| Intersegment revenue IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000MedicalPlatformReportableSegmentMember | 739000000 | JPY |
| Intersegment revenue IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000EvidenceSolutionReportableSegmentMember | 174000000 | JPY |
| Intersegment revenue IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000CareerSolutionReportableSegmentMember | 178000000 | JPY |
| Intersegment revenue IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000SiteSolutionReportableSegmentMember | － | JPY |
| Intersegment revenue IFRS | Prior1QuarterDuration_jpcrp040300-q3r_E05425-000OverseasReportableSegmentMember | 17000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |